FDA-Approved Ingredient Linked to Blood Clot Dangers

A “zero-calorie” sweetener can linger in your bloodstream for days at levels tied to blood clots—and that’s the part no one put on the label.

Quick Take

A 2023 Cleveland Clinic study linked high blood levels of erythritol to about double the risk of major cardiac events in higher-risk patients over three years.
Lab and animal work in the same research line showed platelet activation and faster clot formation, matching the clinical signal.
A single 30-gram serving pushed blood levels over 1,000-fold and stayed elevated for more than two days in a small human test.
Erythritol has held FDA “GRAS” status since 2001, but long-term outcome trials were never required before widespread use in keto and “sugar-free” foods.

The Sweetener That Behaves Like a Drug Dose

Erythritol sells itself as the grown-up compromise: sweet taste, no sugar spike, “natural,” and friendly to low-carb or diabetic diets. The Cleveland Clinic team didn’t go looking for a food additive villain; they were scanning blood for compounds that predict heart trouble. Erythritol stood out. Patients with the highest blood levels landed in a risk tier that tracked with real-world outcomes: more heart attacks, strokes, and deaths.

The detail that should freeze any label-reader mid-aisle was not the word “association,” but the magnitude. In a controlled part of the work, a 30-gram dose—roughly what you can get from a single sweetened drink or dessert—sent blood levels soaring more than 1,000-fold, staying high for over two days. That’s not “a little sugar alcohol passing through.” That’s a sustained exposure window.

What the 2023 Findings Actually Said—And What They Didn’t

The headline number was simple enough for ordinary people: among 1,157 patients already at cardiac risk, those with erythritol levels in the top quarter had roughly double the rate of major adverse cardiovascular events over three years, reported as about 12 versus 7 events per 100 people. That framing matters because it’s not abstract chemistry; it’s outcomes families recognize. Still, the study observed a link; it did not prove erythritol caused each event.

The researchers tried to close the “so what?” gap with mechanism. In lab tests, erythritol increased platelet responsiveness—exactly the kind of change you’d expect if clotting risk goes up. Mouse models of vascular injury showed clot formation sped up under erythritol exposure. That combination—human outcomes plus biological plausibility—makes the signal harder to dismiss as a statistical fluke, even while conservative readers should keep one rule intact: correlation alone isn’t a conviction.

Who Faces the Most Risk: Heavy Users and the Medically Motivated

The pattern emerging from the research is not “everyone who tastes erythritol is doomed.” The elevated event rates showed up in the high-exposure group—top quartile blood levels. That aligns with real life: the people most likely to stack erythritol across the day are the dutiful label-checkers trying to do the right thing—cut sugar, control weight, keep glucose down. Keto devotees can easily combine multiple “no sugar added” products before lunch.

Researchers and outside commentators also raised a fair question: could higher-risk people generate more erythritol internally, meaning high blood levels might mark illness rather than cause it? That uncertainty is exactly why randomized trials matter. But the “one serving spikes levels for days” finding undercuts the idea that diet doesn’t play a major role. If one drink can keep levels elevated past two nights of sleep, chronic consumers may never return to baseline.

The 2025 Brain-and-Heart Warning: A Second Line of Concern

A 2025 report from the American Physiological Society widened the spotlight: erythritol exposure in human brain microvascular endothelial cells increased oxidative stress and reduced nitric oxide, a molecule essential for healthy vessel function and blood flow. Reduced nitric oxide is not a boutique lab curiosity; it points toward impaired vasodilation—bad news in the brain and heart, where tight vessels and fragile oxygen delivery can turn small problems into strokes or heart attacks.

Taken with the earlier platelet and clotting work, the story becomes more coherent: one line of evidence points to thicker traffic (clotting), another to narrower roads (endothelial dysfunction). Neither replaces a randomized outcome trial, but together they justify skepticism toward the marketing glow around “natural zero-calorie.” American consumers have every right to demand that “better for you” claims rest on more than trend-driven substitution.

What to Do Before Regulators Catch Up

Practical caution doesn’t require panic. If you’re older, diabetic, pre-diabetic, have a history of stroke, heart disease, stents, atrial fibrillation, or clotting problems—or if you take blood thinners—treat heavy erythritol intake as a question for your clinician, not a harmless hack. Start by tallying your real exposure: beverages, keto desserts, protein snacks, tabletop sweeteners. “A little” adds up fast when every product is engineered to taste like dessert.

Until randomized trials clarify causality and dose thresholds, avoid making erythritol your daily workhorse sweetener. Reduce ultra-processed “diet” foods that hide it, favor whole foods that don’t need sweetener engineering, and remember the core trade-off: swapping sugar for a lab-refined substitute can still be a high-stakes bet. The biggest risk may be trusting the label more than the biology.